HeartBeam, Inc. (BEAT) balance sheet

BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30

$0.55+0.01 (+2.06%)

Close on Oct 30, 2026Market cap $659.29KP/E –Yield –

HeartBeam, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Cash & Equivalents	4.38	2.43	16	3.59	13	0.02	0.01
Cash & Short-Term Investments	4.40	2.40	16	3.59	13	0.02	0.01
Inventory	0.10	0	–	–	–	–	–
Prepaid Expenses & Other	0.20	0.39	0.64	0.45	0.81	0.03	–
Total Current Assets	4.69	2.77	17	4.04	–	–	–
Property, Plant & Equipment	1.10	0.45	0.26	0	–	–	–
Gross Property, Plant & Equipment	1.15	–	–	–	–	–	–
Accumulated Depreciation	-0.05	–	–	–	–	–	–
Construction in Progress	–	–	0.26	–	–	–	–
Other Long-Term Assets	0.06	0.06	0.05	0	–	–	–
Total Assets	5.84	3.28	17	4.04	14	0.05	–
Accounts Payable	1.05	0.53	0.56	1.67	0.59	0.49	–
Accrued Expenses	2.19	1.09	0.64	–	–	–	–
Other Current Liabilities	–	–	–	–	0	0.05	–
Total Current Liabilities	3.24	1.62	1.19	–	–	4.84	–
Total Liabilities	3.24	1.62	1.19	1.67	0.59	4.84	–
Preferred Stock	0	0	0	0	0	–	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0	–
Additional Paid-In Capital	80	58	53	25	23	0.01	–
Retained Earnings	-77	-56	-37	-22	-9.22	-4.80	–
Shareholders' Equity	2.60	1.65	16	2.37	13	-4.79	-3.73
Total Equity	2.60	1.65	16	2.37	13	-4.79	-3.73
Total Liabilities & Equity	5.84	3.28	17	4.04	14	0.05	–
Shares Outstanding(shares)	40	27	26	8.01	7.81	3.53	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -987.3%

Financial strength

Current ratio: 3.66
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 354.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.08
Dividend yield: –